The American Society of Clinical Oncology (ASCO) will honor Hoosier Cancer Research Network co-founder Patrick J. Loehrer, Sr., MD, FASCO, with the inaugural Allen S. Lichter Visionary Leader Award and Lecture during the ASCO annual meeting, June 2-6 in Chicago. ASCO created the award in 2016 to recognize members who have transformed the oncology field or significantly advanced the mission of ASCO, the Conquer Cancer Foundation, or CancerLinQ, LLC, through their leadership, vision, and ability to inspire.

Dr. Loehrer is recognized as a prolific clinical researcher and specialist in the treatment of a variety of cancers including testis, bladder, colon, pancreas, and, most notably, thymic, a rare cancer of the thymus gland. His research on the drug ifosfamide led to its approval by the FDA. Dr. Loehrer is the director of the Indiana University Melvin and Bren Simon Cancer Center and the associate dean for cancer research at the Indiana University School of Medicine. Dr. Loehrer was HCRN’s founding chair for two decades.

“For Hoosier Cancer Research Network, visionary leadership is embodied most truly by Dr. Loehrer. From the early days of the Hoosier Oncology Group more than 30 years ago, to our standing today as a nationwide, full-service, nonprofit clinical research organization, Dr. Loehrer has been a constant champion, friend, and guiding voice to our organization,” said HCRN Executive Director Cyndi Burkhardt, RN. “We are proud to celebrate ASCO’s recognition of Dr. Loehrer.”

About ASCO:

Founded in 1964, the American Society of Clinical Oncology (ASCO) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents more than 40,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at www.ASCO.org, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube.

About Hoosier Cancer Research Network:

Hoosier Cancer Research Network (formerly known as Hoosier Oncology Group) conducts innovative cancer research in collaboration with academic and community physicians and scientists across the United States. The organization provides comprehensive clinical trial management and support, from conception through publication. Created in 1984 as a program of the Walther Cancer Institute, Hoosier Cancer Research Network became an independent nonprofit clinical research organization in 2007. Since its founding, Hoosier Cancer Research Network has initiated more than 160 trials in a variety of cancer types and supportive care, resulting in more than 300 publications. More than 5,000 subjects have participated in Hoosier Cancer Research Network clinical trials.